Drugs / Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07711132 | Dec 2025 → Dec 2026 expected | enamel caries | Mansoura University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07711132 ↗ |
| Known as | GC Tooth Mousse | “CPP-ACP paste (GC Tooth Mousse)” NCT07711132 ↗ |
| Route | Topical | “paste was applied daily by participants after tooth brushing at bedtime and left on teeth” NCT07711132 ↗ |